Clinical Trials Directory

Trials / Completed

CompletedNCT04005040

Evaluation of Mobile X-ray Within the Triple Aim Method

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
374 (actual)
Sponsor
University of Aarhus · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

Background: In foreign countries, mobile x-ray already is being used where transfer to the radiology department at the hospital may be an obstacle. Using mobile x-ray, the x-ray examination is performed in the patients own home with transportable equipment that reminds of the transportable x-ray equipment that is being used in the intensive care units. At The Department of Radiology (DOR), Aarhus University Hospital there is an ongoing project mobile x-ray for patients living in nursing homes in Aarhus. The project will be evaluated inspired by the Triple Aim Approach in three sub studies. Overall aim: The overall aim is to conclude if mobile x-ray improves healthcare for fragile patients. Hypotheses: * Patients examined with mobile x-ray have fewer number of hospital admissions compared with patients examined with x-ray at DOR. * Patients examined with mobile x-ray are more satisfied with their examination compared with patients examined with x-ray at DOR. Sub study 1 - Population health Aim: The primary aim is to study if mobile x-ray improves the health of the defined population measured in hospital admission. Also to study challenges conducting a RCT. The outcome measures: The primary outcome is hospital admissions. Sub study 2 - Experience of care Aim: The aim is to study the satisfaction with mobile x-ray compared the satisfaction to x-ray at DOR. Methods: Observations, interview and questionnaires.

Conditions

Interventions

TypeNameDescription
PROCEDUREMobile X-rayEvaluating the effect of mobile x-ray compared to x-ray at the Hospital

Timeline

Start date
2018-05-01
Primary completion
2019-04-17
Completion
2019-04-17
First posted
2019-07-02
Last updated
2020-04-22

Locations

1 site across 1 country: Denmark

Source: ClinicalTrials.gov record NCT04005040. Inclusion in this directory is not an endorsement.